TPDC-FuHu chemotherapy for the treatment of recurrent metastatic brain tumors.

Kaba, S E; Kyritsis, A P; Hess, K; Yung, W K; Mercier, R; Dakhil, S; Jaeckle, K A; Levin, V A

Kaba, S E; Kyritsis, A P; Hess, K; Yung, W K; Mercier, R; Dakhil, S; Jaeckle, K A; Levin, V A.

Affiliation

Kaba SE; Department of Neuro-Oncology and Biomathematics, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.

J Clin Oncol ; 15(3): 1063-70, 1997 Mar.

Article in En | MEDLINE | ID: mdl-9060546

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Brain Neoplasms/drug therapy; Adenocarcinoma/drug therapy; Adenocarcinoma/secondary; Adult; Age Factors; Aged; Brain Neoplasms/secondary; Breast Neoplasms/pathology; Carcinoma, Non-Small-Cell Lung/drug therapy; Carcinoma, Non-Small-Cell Lung/secondary; Carcinoma, Small Cell/drug therapy; Carcinoma, Small Cell/secondary; Disease Progression; Female; Fluorouracil/administration & dosage; Humans; Hydroxyurea/administration & dosage; Lomustine/administration & dosage; Lung Neoplasms/pathology; Male; Middle Aged; Mitolactol/administration & dosage; Procarbazine/administration & dosage; Prospective Studies; Thioguanine/administration & dosage

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 1997 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links